Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250449156> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4250449156 abstract "S<a>odium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i)</a> effectively lower plasma glucose (PG) concentration in patients with type 2 diabetes, but studies suggest that circulating glucagon concentrations and endogenous glucose production (EGP) are increased by SGLT2i, possibly compromising their glucose-lowering ability. To tease out whether and how glucagon may influence the glucose-lowering effect of SGLT2 inhibition, we subjected 12 patients with type 2 diabetes to a randomized, placebo-controlled, double-blinded, crossover, double-dummy study comprising, on four separate days, a liquid mixed meal test preceded by single-dose administration of either 1) placebo, 2) the SGLT2i empagliflozin (25 mg), 3) the glucagon receptor antagonist LY2409021 (300 mg), and 4) the combination <a>empagliflozin+LY2409021</a>. Empagliflozin and LY2409021 individually lowered fasting PG compared to placebo and the combination further decreased fasting PG. Previous findings of increased glucagon concentrations and EGP during acute administration of SGLT2i were not replicated in this study. Empagliflozin reduced postprandial PG via increased urinary glucose excretion. LY2409021 reduced EGP significantly, but gave rise to a paradoxical increase in postprandial PG excursion, which was annulled by empagliflozin during their combination (empagliflozin+LY2409021). In conclusion, our findings do not support that an SGLT2i-induced glucagonotropic effect is of importance for the glucose-lowering property of SGLT2 inhibition." @default.
- W4250449156 created "2022-05-12" @default.
- W4250449156 creator A5004120950 @default.
- W4250449156 creator A5010236740 @default.
- W4250449156 creator A5011740404 @default.
- W4250449156 creator A5014406184 @default.
- W4250449156 creator A5052123970 @default.
- W4250449156 creator A5060170508 @default.
- W4250449156 creator A5079352451 @default.
- W4250449156 creator A5085434984 @default.
- W4250449156 creator A5090613510 @default.
- W4250449156 date "2020-10-01" @default.
- W4250449156 modified "2023-09-28" @default.
- W4250449156 title "The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition" @default.
- W4250449156 doi "https://doi.org/10.2337/figshare.13010123.v1" @default.
- W4250449156 hasPublicationYear "2020" @default.
- W4250449156 type Work @default.
- W4250449156 citedByCount "0" @default.
- W4250449156 crossrefType "posted-content" @default.
- W4250449156 hasAuthorship W4250449156A5004120950 @default.
- W4250449156 hasAuthorship W4250449156A5010236740 @default.
- W4250449156 hasAuthorship W4250449156A5011740404 @default.
- W4250449156 hasAuthorship W4250449156A5014406184 @default.
- W4250449156 hasAuthorship W4250449156A5052123970 @default.
- W4250449156 hasAuthorship W4250449156A5060170508 @default.
- W4250449156 hasAuthorship W4250449156A5079352451 @default.
- W4250449156 hasAuthorship W4250449156A5085434984 @default.
- W4250449156 hasAuthorship W4250449156A5090613510 @default.
- W4250449156 hasBestOaLocation W42504491561 @default.
- W4250449156 hasConcept C126322002 @default.
- W4250449156 hasConcept C134018914 @default.
- W4250449156 hasConcept C142724271 @default.
- W4250449156 hasConcept C16613235 @default.
- W4250449156 hasConcept C185592680 @default.
- W4250449156 hasConcept C204787440 @default.
- W4250449156 hasConcept C27081682 @default.
- W4250449156 hasConcept C2775887513 @default.
- W4250449156 hasConcept C2776398474 @default.
- W4250449156 hasConcept C2777180221 @default.
- W4250449156 hasConcept C2778199505 @default.
- W4250449156 hasConcept C2778563252 @default.
- W4250449156 hasConcept C2779306644 @default.
- W4250449156 hasConcept C555293320 @default.
- W4250449156 hasConcept C71924100 @default.
- W4250449156 hasConceptScore W4250449156C126322002 @default.
- W4250449156 hasConceptScore W4250449156C134018914 @default.
- W4250449156 hasConceptScore W4250449156C142724271 @default.
- W4250449156 hasConceptScore W4250449156C16613235 @default.
- W4250449156 hasConceptScore W4250449156C185592680 @default.
- W4250449156 hasConceptScore W4250449156C204787440 @default.
- W4250449156 hasConceptScore W4250449156C27081682 @default.
- W4250449156 hasConceptScore W4250449156C2775887513 @default.
- W4250449156 hasConceptScore W4250449156C2776398474 @default.
- W4250449156 hasConceptScore W4250449156C2777180221 @default.
- W4250449156 hasConceptScore W4250449156C2778199505 @default.
- W4250449156 hasConceptScore W4250449156C2778563252 @default.
- W4250449156 hasConceptScore W4250449156C2779306644 @default.
- W4250449156 hasConceptScore W4250449156C555293320 @default.
- W4250449156 hasConceptScore W4250449156C71924100 @default.
- W4250449156 hasLocation W42504491561 @default.
- W4250449156 hasLocation W42504491562 @default.
- W4250449156 hasOpenAccess W4250449156 @default.
- W4250449156 hasPrimaryLocation W42504491561 @default.
- W4250449156 hasRelatedWork W11444936 @default.
- W4250449156 hasRelatedWork W1479920 @default.
- W4250449156 hasRelatedWork W43171 @default.
- W4250449156 hasRelatedWork W6575098 @default.
- W4250449156 hasRelatedWork W7724539 @default.
- W4250449156 hasRelatedWork W8868324 @default.
- W4250449156 hasRelatedWork W9343845 @default.
- W4250449156 hasRelatedWork W9548945 @default.
- W4250449156 hasRelatedWork W4206524 @default.
- W4250449156 hasRelatedWork W4445067 @default.
- W4250449156 isParatext "false" @default.
- W4250449156 isRetracted "false" @default.
- W4250449156 workType "article" @default.